Editas: 3Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Editas Medicine Inc. (EDIT) on Tuesday reported a loss of $32.9 million in its third quarter.
The Cambridge, Massachusetts-based company said it had a loss of 66 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 73 cents per share.
The genome editing company posted revenue of $3.8 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $4.1 million.
Editas shares have fallen 10% since the beginning of the year. The stock has decreased 30% in the last 12 months.